$CBIS IRVINE, CA--(Marketwired - Sep 13, 2016) -

$CBIS IRVINE, CA--(Marketwired - Sep 13, 2016) - Cannabis Science, Inc. ( OTC PINK : CBIS ), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce that thus far more than 100 individuals have expressed interest in participating in the initial round of trials for Cannabis Science's new inhalation study for asthma/COPD and other respiratory conditions. The company has been thoroughly impressed with the interest in their alternative treatment.

https://finance.yahoo.com/news/cannabis-scien...20336.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!